Karyopharm Therapeutics, Inc. (KPTI)

8.82 -0.33 (-3.61%) USD  |  NASDAQ  |  Mar 05, 16:00
8.77 -0.05 (-0.57%) After-Hours: 20:00
More

Karyopharm Therapeutics Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for KPTI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Alnylam Pharmaceuticals, Inc. Upgrade
Baxter International, Inc. Upgrade
Bruker Corp. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade
Agios Pharmaceuticals, Inc. Upgrade